Considering the high heterogeneity seen in cancers, and the fact that FAP enhances tumor growth and formation of metastases [22,23,24] by modulating tumor vessel formation and migration of myofibroblasts into tumors [25], the consideration of other stromal markers for bispecific tumor targeting alongside FAP, is vital. This evidence concerns the gene FAP and cancer.